Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 104 institutions that hold shares in the stock, with a total of 81.7 Million shares, which have been reported (via 13F filing form) to have a value of $206 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Three Bridge Wealth Advisors, LLC
Portola Valley, CA |
Oct 21, 2025 Q3 2025 |
714,823
shares
|
$1.8 Million
0.35% of portfolio
|
Q3 2025
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
700,823
shares
|
$1.77 Million
0.0% of portfolio
|
Q3 2025
Reduced 8.54%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
544,760
shares
|
$1.37 Million
0.0% of portfolio
|
Q3 2025
Added 6.95%
|
|
|
Aisling Capital Management LP
New York, NY |
Nov 12, 2025 Q3 2025 |
434,455
shares
|
$1.09 Million
0.19% of portfolio
|
Q4 2022
Reduced 31.52%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2025 Q3 2025 |
393,319
shares
|
$991,163
0.02% of portfolio
|
Q3 2025
Reduced 11.28%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
373,682
shares
|
$941,678
0.07% of portfolio
|
Q3 2025
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
368,107
shares
|
$927,629
0.0% of portfolio
|
Q3 2025
Reduced 50.9%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
350,100
shares
|
$882,252
0.0% of portfolio
|
Q3 2025
Reduced 54.19%
|
|
|
High Tower Advisors, LLC
Chicago, IL |
Nov 06, 2025 Q3 2025 |
309,317
shares
|
$779,478
0.0% of portfolio
|
Q3 2025
Reduced 3.88%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Nov 14, 2025 Q3 2025 |
283,476
shares
|
$714,359
0.0% of portfolio
|
Q3 2025
Added 2.24%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
241,956
shares
|
$609,729
0.0% of portfolio
|
Q3 2025
Reduced 7.4%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
237,830
shares
|
$599,331
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
Nov 13, 2025 Q3 2025 |
192,900
shares
|
$486,108
0.3% of portfolio
|
Q3 2025
Reduced 60.74%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
164,244
shares
|
$413,894
0.0% of portfolio
|
Q3 2025
Reduced 20.76%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
162,463
shares
|
$409,406
0.0% of portfolio
|
Q3 2025
Added 20.05%
|
|
|
Assenagon Asset Management S.A.
|
Oct 07, 2025 Q3 2025 |
154,554
shares
|
$389,476
0.0% of portfolio
|
Q3 2025
Reduced 16.27%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
140,167
shares
|
$353,220
0.0% of portfolio
|
Q3 2025
Reduced 15.75%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
123,425
shares
|
$311,031
0.0% of portfolio
|
Q3 2025
Reduced 21.05%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
105,138
shares
|
$264,947
0.0% of portfolio
|
Q3 2025
Reduced 31.36%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
91,236
shares
|
$229,914
0.0% of portfolio
|
Q3 2025
Added 7.38%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
75,191
shares
|
$189,481
0.0% of portfolio
|
Q3 2025
Added 3.58%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
73,113
shares
|
$184,244
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
68,039
shares
|
$171,458
0.0% of portfolio
|
Q3 2025
Added 8.27%
|
|
|
Algert Global LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
65,630
shares
|
$165,387
0.0% of portfolio
|
Q3 2025
Added 64.69%
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
63,925
shares
|
$161,091
0.01% of portfolio
|
Q3 2025
Added 167.28%
|
|